Onco-Innovations Limited
Onco-Innovations Limited
CSE Index:
NoCurrency:
CAD Onco-Innovations Limited is a Canadian biotech company dedicated to developing and commercializing treatments for various types of cancer. The company holds an exclusive license for the PNKP Inhibitor Technology and an exclusive sublicense for the Drug Delivery Technology. Together, these technologies have shown the potential to significantly enhance treatment outcomes, particularly for colorectal cancer.
Onco-Innovations Limited (ONCO)
1.03
-0.34 (-24.82%)
Onco-Innovations Limited (ONCO)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Bid Size
5,000
Bid Price
0.87
Ask Price
1.03
Ask Size
6,200
Volume
210,480
Last Price
1.03
Tick
Net Change
-0.34
Prev Close
1.37
Open
1.28
Day High
1.33
Day Low
0.90
52 Week High
2.80
52 Week Low
0.56
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
2.48
Tick
Net Change
Prev Close
2.48
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
5,000
Bid Price
0.87
Ask Price
1.03
Ask Size
6,200
Volume
210,480
Last Price
1.03
Tick
Net Change
-0.34
Prev Close
1.37
Open
1.28
Day High
1.33
Day Low
0.90
52 Week High
2.80
52 Week Low
0.56
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
2.48
Tick
Net Change
Prev Close
2.48
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| Desjardins Securities Inc. | 5,000 | 0.87 | 1.03 | 1,200 | RBC Capital Markets |
| Canaccord Capital Corporation | 7,500 | 0.85 | 1.03 | 2,500 | RBC Capital Markets |
| National Bank Financial Inc. | 100 | 0.85 | 1.03 | 2,500 | RBC Capital Markets |
| W.D. Latimer Co. Limited | 500 | 0.75 | 1.10 | 1,000 | Anonymous |
| W.D. Latimer Co. Limited | 1,000 | 0.75 | 1.15 | 200 | Anonymous |
| W.D. Latimer Co. Limited | 5,000 | 0.50 | 1.15 | 1,000 | Anonymous |
| TD Securities Inc. | 5,000 | 0.30 | 1.23 | 1,900 | Instinet Canada Limited |
| 0 | 0.00 | 1.25 | 1,000 | Anonymous | |
| 0 | 0.00 | 1.27 | 1,000 | Anonymous | |
| 0 | 0.00 | 1.30 | 1,000 | Anonymous |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 1 | 5,000 | 0.87 | 1.03 | 6,200 | 3 |
| 2 | 7,600 | 0.85 | 1.10 | 1,000 | 1 |
| 2 | 1,500 | 0.75 | 1.15 | 1,200 | 2 |
| 1 | 5,000 | 0.50 | 1.23 | 1,900 | 1 |
| 1 | 5,000 | 0.30 | 1.25 | 1,000 | 1 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Mar 18, 19:59 | 1.03 | 0.00 | 500 | Anonymous | RBC Capital Markets | CSE |
| Mar 18, 19:58 | 1.02 | -0.01 | 2,600 | Questrade Inc. | CIBC World Markets Inc. | CSE |
| Mar 18, 19:55 | 1.00 | -0.03 | 500 | Canaccord Capital Corporation | CIBC World Markets Inc. | CSE |
| Mar 18, 19:55 | 1.00 | -0.03 | 5,000 | Canaccord Capital Corporation | Anonymous | CSE |
| Mar 18, 19:54 | 0.95 | -0.08 | 1,100 | Canaccord Capital Corporation | Anonymous | CSE |
Company Info
Address
1309-7th Street SW
Vancouver, BC V6C 2B5
CanadaPhone
(236) 521-0626Email
nl@amalficorp.caWebsite
https://www.oncoinnovations.comListing date
Tuesday, November 26, 2024Transfer Agent
Endeavor Trust CorporationSEDAR Information
Filing Type
Any
News Releases
Material Change Report
Management's Discussion & Analysis
Financial Statements
Timeframe
1 week1 month3 month6 month1 yearAll Time
Onco-Innovations Limited
Date:
Feb 4, 2025
Onco-Innovations Limited
Date:
Nov 22, 2024
Onco-Innovations Limited
Date:
Nov 22, 2024
Onco-Innovations Limited
Date:
Oct 4, 2024
Onco-Innovations Limited
Date:
Oct 4, 2024
Onco-Innovations Limited
Date:
Aug 1, 2024
Onco-Innovations Limited
Date:
Aug 1, 2024
Onco-Innovations Limited
Date:
Aug 1, 2024
Onco-Innovations Limited
Date:
Aug 1, 2024
Onco-Innovations Limited
Date:
Apr 4, 2024
Company Info
Address
1309-7th Street SW
Vancouver, BC V6C 2B5
CanadaPhone
(236) 521-0626Email
nl@amalficorp.caWebsite
https://www.oncoinnovations.comListing date
Tuesday, November 26, 2024Transfer Agent
Endeavor Trust CorporationCapitalization
Issued & Outstanding:
47153310Reserved for Issuance:
8006583Company Officers
Thomas O'Shaughnessy, CEO
Nico Mah, CFO and Corporate Secretary
News Releases
Bulletins
26/11/2024
2024-1133 - New Listing - Onco-Innovations Limited (ONCO)
Le 26 novembre/November 2024
The common shares of Onco-Innovations Limited have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
CSE Filings
